Nalbuphine Hydrochloride 00409-1465-01

Package NDC

00409-1465-01

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intramuscular, Intravenous, And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: December 31, 2004
Listing Expires: December 31, 2026
Application: ANDA070916

Need to source Nalbuphine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Nalbuphine Hydrochloride	20 mg/mL

Drug Class

Competitive Opioid Antagonists [MoA]Opioid Agonist/Antagonist [EPC]Partial Opioid Agonists [MoA]

Selected Package

00409-1465-01Selected

10 AMPULE in 1 TRAY (0409-1465-01) / 1 mL in 1 AMPULE (0409-1465-71)